CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

The Role of Pharmaceutical Wholesalers in the Drug Industry

The Role of Pharmaceutical...

Technology-driven Innovations To Stimulate the Capability in Agricultural Practices

Technology-driven Innovations To...

The Life Science Marketing To Accelerate In the Future With Tech-driven Genetics Innovations

The Life Science Marketing To...

Singapore Among the Top Life Science Hubs in APAC

Singapore Among the Top Life Science...

Emerging Life Science Trends in 2023

Emerging Life Science Trends in 2023

Emerging Life Science Marketing and Industry Trends for 2023

Emerging Life Science Marketing and...

The Vital Role of CROs in the Drug Development Journey

The Vital Role of CROs in the Drug...

CRO Consolidation to Bring New Developments to Clinical Trials

CRO Consolidation to Bring New...

The Role of Pharmaceutical Wholesalers in the Drug Industry

The Role of Pharmaceutical...

Technology-driven Innovations To Stimulate the Capability in Agricultural Practices

Technology-driven Innovations To...

The Life Science Marketing To Accelerate In the Future With Tech-driven Genetics Innovations

The Life Science Marketing To...

Singapore Among the Top Life Science Hubs in APAC

Singapore Among the Top Life Science...

Emerging Life Science Trends in 2023

Emerging Life Science Trends in 2023

Emerging Life Science Marketing and Industry Trends for 2023

Emerging Life Science Marketing and...

The Vital Role of CROs in the Drug Development Journey

The Vital Role of CROs in the Drug...

CRO Consolidation to Bring New Developments to Clinical Trials

CRO Consolidation to Bring New...

Synthetic Biology to Increase Environmental Sustainability of Life Sciences

Life Sciences Review | Tuesday, October 18, 2022
Tweet

Businesses should learn to use syn-bio to develop new products and processes, improve existing ones, and reduce costs to remain competitive in the future as synthetic biology technologies are advancing and becoming the way almost anything can be manufactured competitively and sustainably.


FREMONT, CA:Synthetic biology or Syn-bio has become a disruptive force giving rise to the Bio-Economy. Syn-bio has turned science into the manufacturing paradigm of the future. With microorganisms creating things that industrial processes currently manufacture, syn-bio offers new ways of producing everything human beings consume, from flavours and fabric to foods and fuels.


Today, supply is no longer constrained by the availability of raw materials. Companies can engineer and manufacture an infinite number of products from the beginning. Syn-bio has given rise to the industry of science-based start-ups trying to change conventional products and processes, transforming the material world.


New genome-editing technologies like CRISPR-Cas9 help to create novel DNA combinations, reduce editing DNA costs, and increase the length of DNA strands that can be replicated without error. The improving viability of cell-free biology allows companies to use metabolic cell processes that do not require live cells and make testing faster using biosensors. Like data and cloud computing, DNA and DNA editing are spurring the creation of a new production frontier.


Syn-bio is expected to be used extensively in manufacturing industries that account for more than a third of global output. 


In fact, due to real-time data collection, automation, and AI, few sectors feel more impact than others. However, incumbents in industries like health and beauty, medical devices, and electronics will be challenged by syn-bio rivals as the pharmaceutical and food companies have already been. Industries like chemicals, textiles, fashion, and water will encounter cost-based competition from syn-bio alternatives in the medium run, followed in the long term by firms such as mining, electricity, and even construction.


With the increasing world biology knowledge, declining DNA writing and editing costs, and synthesising tools becoming easier to use, Syn-bio’s frontiers will continue to expand. New products and processes will be created similar to science fiction but ripe to go mainstream. In addition, the syn-bio start-ups are engineering more sustainable products consuming fewer resources, such as land and water, and avoiding fossil fuels usage and their derivatives. These products are also more durable, generate less waste after use, and are healthier for humans in many cases. Adopting this interesting technology immediately is essential, especially since business and science have tended to function in separate spheres until now. Companies also need to learn to use syn-bio to gain a competitive advantage, a sustainable one.


Furthermore, syn-bio pioneers are using science to achieve five different goals such as improving the performance of existing products or processes, reducing the costs or increasing the availability of scarce raw materials, creating products or raw materials that are more environmentally friendly, and catalyse resilient supply chains.


Weekly Brief

loading
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Antibodies: Immunoglobulin Isotypes

Life Science Consulting Services Trends

Rani Therapeutics and Celltrion Partner to Develop Oral Monoclonal Antibodies

ProPhase Labs Acquires BE-Smart Esophageal Pre-Cancer Screening Test

The Influence of Pharmaceutical Distributors on U.S. Drug Expenditures

Tips to Improve Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/synthetic-biology-to-increase-environmental-sustainability-of-life-sciences-nwid-1009.html